Next 10 |
home / stock / lxxgf / lxxgf news
LexaGene Holdings ( OTCQB:LXXGF ) has filed a voluntary petition for relief under Chapter 7 of the U.S. Bankruptcy Code. The molecular diagnostics company said it has ceased operations and laid off its staff. A U.S. court is set to appoint a bankruptcy trustee to liquidate t...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...
BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab TM System for autom...
BEVERLY, Mass. , Dec. 16, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automated, ge...
BEVERLY, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab® System for automate...
BEVERLY, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System for automated...
BEVERLY, Mass., Oct. 27, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab® System for automated...
Molecular diagnostics company LexaGene ( OTCQB:LXXGF ) has entered secured convertible note agreement with Meridian LGH, an affiliate of an insider of the company, in the aggregate principal amount of up to $1.6M. The note bears interest at 12% per annum and matures on Ma...
News, Short Squeeze, Breakout and More Instantly...
BEVERLY, Mass., Feb. 24, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), announces that it has ceased operations, laid off its staff, and, together with its direct subsidiary LexaGene, Inc., and its indir...
BEVERLY, Mass., Feb. 10, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“ LexaGene ” or the “ Company ”), a molecular diagnostics company that has commercialized the MiQLab™ System for automated mul...
BEVERLY, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc. , ( OTCQB: LXXGF ; TSX-V: LXG ) (“LexaGene” or the “Company”), an innovative, molecular diagnostics company that has commercialized the MiQLab™ System for automate...